Quantcast

Latest Influenza vaccine Stories

2014-05-06 04:22:59

High level of vaccination, and low level of flu, among seniors NEW YORK, May 6, 2014 /PRNewswire/ -- Last winter's flu season was fairly typical of other winters over the last decade, with the prevalence of the flu and the number of people who had flu shots both fairly close to the averages for that time period. The effectiveness of flu vaccines also seems to have been fairly typical. http://photos.prnewswire.com/prnvar/20100517/NY06256LOGO These are some of the results of The Harris Poll of...

2014-04-30 23:12:14

MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas (PRWEB) April 30, 2014 The report titled “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the market dynamics and various trends and opportunities associated with the global Influenza vaccine market. It covers the global market size and growth dynamics of the influenza...

2014-04-29 23:03:36

The National Foundation for Infectious Diseases (NFID) has been selected as the Honorable Mention recipient of the 2014 National Adult and Influenza Immunization Summit (NAIIS) Immunization Excellence Award for Overall Flu Season Activities. Bethesda, Maryland (PRWEB) April 29, 2014 The National Foundation for Infectious Diseases (NFID) has been selected as the Honorable Mention recipient of the 2014 National Adult and Influenza Immunization Summit (NAIIS) Immunization Excellence Award...

2014-04-28 12:31:40

Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries KING OF PRUSSIA, Pa., April 28, 2014 /PRNewswire/ -- bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influenza vaccine to the Partnership for Influenza Vaccine Introduction, an innovative program - spearheaded by the U.S. Centers for Disease Control and Prevention (CDC) and the Task Force for...

2014-04-28 08:30:45

Collaborating with World Health Organization and Intravacc to Develop sIPV in line with mission to secure a lasting polio-free world, free of all paralytic polio disease BEIJING, April 28, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has entered into a license agreement with Intravacc (Institute for...

2014-04-25 08:27:29

National Infant Immunization Week is April 26 - May 3, 2014 ATLANTA, April 25, 2014 /PRNewswire/ -- National Infant Immunization Week (NIIW) is April 26 - May 3, 2014, and the Georgia Department of Public Health (DPH) urges all Georgians to protect infants from vaccine-preventable diseases by getting them vaccinated on time, every time. "Vaccinating your infant is the best way to protect them from serious illnesses like whooping cough and measles," said Steven Mitchell, Director of...

2014-04-24 23:06:13

Healthcare market research firm Kalorama Information says the pharmaceutical giant Novartis benefits a bit more from its recently announced partnership with Glaxo Smith Kline. New York, NY (PRWEB) April 24, 2014 Healthcare market research firm Kalorama Information says the pharmaceutical giant Novartis benefits a bit more from its recently announced partnership with Glaxo Smith Kline....

2014-04-24 08:32:33

RMB 60 Million Free Grant for Construction of Dedicated Production Facility BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China's Ministry of Finance, National Development and Reform Commission, Ministry of Industry and Information Technology, and National Health and Family Planning Commission for...

2014-04-16 08:34:34

BEIJING, April 16, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2013 on April 16, 2014. The Annual Report on Form 20-F is now available on the Company's website under SEC...

2014-04-14 16:24:20

DALLAS, April 14, 2014 /PRNewswire-iReach/ -- ReportsnReports.com adds "Vaccine Development Strategies - Refocusing Efforts to Address New Challenges" report to its research database. Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and bacterial diseases now effectively generated, vaccine R&D is turning to areas of unmet need....


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.